Loading...
PhD Mojca Lunder

PhD Mojca Lunder
no.: 25096 source: ARIS

researcher – active in research organisation
  mojca.lunderat signffa.uni-lj.si
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
354.43
A''
130.19
A'
159.26
A1/2
180.87
CI10
618
CImax
116
h10
14
A1
1.27
A3
0.84
Data for the last 5 years (citations for the last 10 years) on November 10, 2025; Data for score A3 calculation refer to period 2020-2024 (2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 55  767  640  11.64 
Scopus 56  870  747  13.34 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2002 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2008 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  12/1/2003    Researcher  Full professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-60060  Extracellular vesicles from recombinant Lactococcus lactis as novel protein delivery vectors for treatment of intestinal inflammation and prevention of colorectal cancer   1/1/2025 - 12/31/2027  PhD Tina Vida Plavec   1,253 
2. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking   10/1/2023 - 9/30/2026  PhD Peter Korošec   1,549 
3. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   10/1/2021 - 9/30/2024  PhD Borut Štrukelj   3,428 
4. V4-2038  DNA vaccine and peptide inhibitors against SARS-CoV-2   10/1/2020 - 9/30/2022  PhD Roman Jerala   8,795 
5. J4-1767  Selective extraction of high value molecules from forest products processing residues in the speciality chemicals sector   7/1/2019 - 6/30/2022  PhD Andreja Kutnar   4,443 
6. J3-5502  Napake v regulaciji izražanja TDP-43 pri amiotrofični lateralni sklerozi in frontotemporlani lobarni degeneraciji (Slovene)   8/1/2013 - 7/31/2016  PhD Boris Rogelj   5,653 
7. J3-4026  Transport in RNA vezava proteinov TDP-43 in FUS - implikacije za ALS/FTLD spekter nevrodegenerativnih bolezni (Slovene)   7/1/2011 - 6/30/2014  PhD Boris Rogelj   5,006 
8. J3-0488  FUNKCIONALNA ANALIZA NEKODIRAJOČIH RNA PRI PARKINSONOVI BOLEZNI (Slovene)   2/1/2008 - 1/31/2011  PhD Boris Rogelj   2,478 
9. L3-0129  IZVENCELIČNE NUKLEINSKE KISLINE V DIAGNOSTIKI KORONARNE ATEROSKLEROZE (Slovene)   2/1/2008 - 1/31/2011  PhD Darko Černe   2,129 
10. L4-1046  Nove zdravilne učinkovine biotehnološkega izvora z uporabo bakteriofagnega prikaza (Slovene)   2/1/2008 - 1/31/2011  PhD Borut Štrukelj   4,358 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy   1/1/2022 - 12/31/2027 PhD Žiga Jakopin   1,455 
2. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Janko Kos   5,602 
3. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,454 
4. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2009 - 12/31/2014 PhD Janko Kos   5,974 
5. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2004 - 12/31/2008 PhD Janko Kos   5,754 
Views history
Favourite